Understand the source comparison
Best Peptides for Cluster Headaches: Compound Comparison
Thymalin Thymic immune modulation, cytokine regulation Reduces neuroinflammation driven by IL-6, TNF-alpha at trigeminal junction Animal models + immune disorder trials Requires reconstitution, subcutaneous injection, typically 5–10mg doses Cerebrolysin Neurot
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Thymic immune modulation, cytokine regulation
- Reduces neuroinflammation driven by IL-6, TNF-alpha at trigeminal junction
- Animal models + immune disorder trials
- Requires reconstitution, subcutaneous injection, typically 5–10mg doses
- Cerebrolysin
- Neurotrophic factor activation (BDNF), neuroprotection
- May reduce trigeminal nerve sensitisation and support neuroplasticity
- Human trials in stroke, TBI. Not cluster headaches
- IV administration in clinical settings, difficult to self-administer
- KPV
- NF-kB inhibition, anti-inflammatory tripeptide
- Suppresses inflammatory transcription pathways active in cluster attacks
- In vitro + IBD models. No neurological trials
- Oral or subcutaneous, 500mcg–2mg typical research doses
- MK 677
- Ghrelin receptor agonist, GH secretagogue
- Hypothalamic modulation may influence circadian attack triggers
- Human trials for GH deficiency, sarcopenia. Not headache disorders
- Oral administration, 10–25mg daily, half-life ~24 hours
- Dihexa
- HGF receptor agonist, neuroplasticity enhancer
- Could reduce maladaptive trigeminal sensitisation over time
- Cognitive enhancement research. No pain condition trials
- Oral, 1–5mg typical doses, crosses blood-brain barrier efficiently